2Seventy Bio Inc (TSVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,247 | -217,570 | -254,153 | -292,213 | -120,114 |
| Depreciation Amortization | 7,096 | 22,341 | 11,533 | 16,350 | 13,188 |
| Accounts payable and accrued liabilities | -4,397 | -423 | 327 | -6 | -13,240 |
| Other Working Capital | 2,999 | 2,604 | -26,877 | 13,510 | -15,469 |
| Other Operating Activity | -33,449 | 26,190 | 41,030 | 55,504 | 67,842 |
| Operating Cash Flow | $-84,998 | $-166,858 | $-228,140 | $-206,855 | $-67,793 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -531 | -13,865 | -30,810 | -11,575 | -22,261 |
| Purchase Of Investment | -153,271 | -265,173 | -147,884 | -32,997 | N/A |
| Sale Of Investment | 191,565 | 322,899 | 182,447 | 34,986 | N/A |
| Purchase Sale Intangibles | N/A | N/A | 0 | -8,000 | N/A |
| Other Investing Activity | 43,000 | 0 | 0 | -8,000 | 0 |
| Investing Cash Flow | $80,763 | $43,861 | $3,753 | $-17,586 | $-22,261 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 417 | 127,390 | 166,229 | 0 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 354,889 | 90,054 |
| Financing Cash Flow | $417 | $127,390 | $166,229 | $354,889 | $90,054 |
| Beginning Cash Position | 76,683 | 72,290 | 130,448 | N/A | N/A |
| End Cash Position | 72,865 | 76,683 | 72,290 | 130,448 | N/A |
| Net Cash Flow | $-3,818 | $4,393 | $-58,158 | $130,448 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -84,998 | -166,858 | -228,140 | -206,855 | -67,793 |
| Capital Expenditure | -707 | -13,865 | -30,810 | -11,575 | -22,261 |
| Free Cash Flow | -85,705 | -180,723 | -258,950 | -218,430 | -90,054 |